Difference between revisions of "Ferric gluconate (Ferrlecit)"
Jump to navigation
Jump to search
m |
|||
| Line 14: | Line 14: | ||
==Also known as== | ==Also known as== | ||
| − | + | *'''Generic name:''' sodium ferric gluconate complex in sucrose injection | |
| + | *'''Brand name:''' Ferrlecit | ||
==References== | ==References== | ||
| Line 20: | Line 21: | ||
[[Category:Drug index]] | [[Category:Drug index]] | ||
| + | [[Category:Intravenous medications]] | ||
[[Category:Hematology medications]] | [[Category:Hematology medications]] | ||
[[Category:Iron]] | [[Category:Iron]] | ||
[[Category:Drugs FDA approved in 1999]] | [[Category:Drugs FDA approved in 1999]] | ||
Revision as of 23:19, 2 December 2017
General information
Class/mechanism: Iron, which is needed for various biologic processes, including synthesis of hemoglobin and multiple enzymatic processes.[1][2][3]
Route: IV
Extravasation: no information
- 1 mL of Ferrlecit provides 12.5 mg of elemental iron
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
History of changes in FDA indication
- 2/18/1999: FDA approved "for treatment of iron deficiency anemia in patients undergoing chronic hemodialysis who are receiving supplemental erythropoetin therapy."
Also known as
- Generic name: sodium ferric gluconate complex in sucrose injection
- Brand name: Ferrlecit